6
M. MUSTHAFA ET AL.
internal standard on a Bruker 500 MHz spectrometer. 4.1.3. N-((5H-dibenzo[a,d][7]annulen-5-yl)carbamosele-
noyl)furan-2-carboxamide (3)
Melting points were determined in open capillary tubes on a
Lab India melting point apparatus.
Yield: 1.06 g, 76%. Pale yellow solid. m.p.: 140 ꢂC. Anal.
Calc. for C21H16N2O2Se (%): C, 69.98; H, 4.47; N, 7.77; S,
8.90. Found: C, 69.82; H, 4.73; N, 7.59; S, 8.98. UV–vis
(DMF): kmax, nm 287, 309. FT-IR: V, cmꢁ1 3402, 3294
4. Experimental section
1
(N ꢁ H), 3058 (¼C ꢁ H), 1657 (C ¼ O), 1265 (C ¼ Se). H
NMR (500 MHz, CDCl3): d, ppm 11.64 (s, 1H, NH), 9.15 (s,
1H, NH), 7.64 (d, J ¼ 7.3 Hz, 2H), 7.46 (s, 1H), 7.43 (d,
J ¼ 7.6 Hz, 2H), 7.41– 7.37 (m, 3 H), 7.33 (t, J ¼ 7.5 Hz, 3 H),
7.23 (d, J ¼ 3.0 Hz, 1H), 6.80 (s, 1H), 6.49 (d, J ¼ 1.9 Hz,
1H). 13C NMR (125 MHz, CDCl3): d, ppm 178.5 (C ¼ Se),
156.9 (C ¼ O), 146.1, 145.0, 136.5, 133.7, 131.0, 129.7, 128.8,
127.8, 118.3, 114.3, 113.1, 112.0. LC-MS ¼ 425.5 [M – H]–.
4.1. Synthesis of N-dibenzosuberene substituted
compounds (1–3)
Compounds (1–3) were prepared by the following method.
A solution of benzoyl chloride (0.6 mL, 5 mmol) or thio-
phene-2-carbonyl chloride (0.6 mL, 5 mmol) or furan -2-car-
bonyl chloride (0.5 mL, 5 mmol) in dry acetone (25 mL) was
added dropwise to potassium selenocyanate (0.4859 g,
5 mmol) in dry acetone (25 mL). The reaction mixture was
stirred for one hour at room temperature. After cooling,
dibenzosuberenyl amine (1 g, 5 mmol) dissolved in acetone
(30 mL) was added to it dropwise, and the resulting mixture
was refluxed for 2 h at 65 ꢂC. The reaction mixture was
mixed with into hydrochloric acid (0.1 N, 200 mL) and the
resulting pale yellow/brown substance was filtered off.
Recrystallisation purified the solid product from a chloro-
form/ethanol mixture (1/2).
5. Conclusion
Spectroscopic techniques including FTIR, UV–visible, 1H
and 13C NMR spectra were used to characterize and confirm
the structure of dibenzosuberene substituted aroyl sele-
nourea derivatives. The molecular structures were evaluated
using single-crystal X-ray diffraction. Compounds 1 and 2
belong to monoclinic (1) and triclinic (2) crystal systems,
with space groups P121/n1 and P-1, containing four and
two molecules per unit cell, respectively. In vitro antimicro-
bial activity results revealed that compound 3 exhibited
good antibacterial and antifungal activity against tested
microorganisms compared to standards like Streptomycin
and Nystatin. Docking results revealed that compound 3
had the least binding energy against receptor MurB with a
binding energy value of –5.63 kcal/mol. The results indicate
that in silico molecular docking studies correlated well with
the experimental antibacterial activity results.
4.1.1. N-((5H-dibenzo[a,d][7]annulen-5-yl)carbamosele-
noyl)benzamide (1)
Yield: 1.18 g, 78%. Yellow solid. m.p.: 164 ꢂC. Anal. Calc. for
C23H18N2OSe (%): C, 74.57; H, 4.90; N, 7.56. Found: C,
74.31; H, 5.01; N, 7.65. UV–vis (DMF): kmax, nm 285, 312.
FT-IR: V, cmꢁ1 3399, 3311 (N ꢁ H), 3055 (¼C ꢁ H), 1670
1
(C ¼ O), 1283 (C ¼ Se). H NMR (500 MHz, CDCl3): d, ppm
11.89 (s, 1H, NH), 9.04 (s, 1H, NH), 7.77–7.72 (m, 4 H),
7.61 - 7.58 (m, 2 H), 7.52 - 7.38 (m, 8 H), 7.28 (d,
J ¼ 13.1Hz, 1H), 6.88 (s, 1H). 13C NMR (125 MHz, CDCl3):
d, ppm 178.3 (C ¼ Se), 166.4 (C ¼ O), 136.5, 133.8, 133.4,
131.8, 131.0, 129.7, 129.0, 128.8, 127.8, 127.3. LC-MS ¼
419.3 [M – H]–.
Acknowledgements
The authors Moideen Musthafa and Ramaiah Konakanchi are grateful
to MHRD, Government of India, for giving
Research Fellowship.
a
Senior
References
[1] Rayman, M. P. Selenium and Human Health. Lancet 2012, 379,
[2] Ip, C. Lessons from Basic Research in Selenium and Cancer
[3] de Miranda, J. X.; Andrade, F. d O.; Conti, A. d.; Dagli,
M. L. Z.; Moreno, F. S.; Ong, T. P. Effects of Selenium
Compounds on Proliferation and Epigenetic Marks of Breast
Cancer Cells. J. Trace Elem. Med. Biol. 2014, 28, 486–491. DOI:
4.1.2. N-((5H-dibenzo[a,d][7]annulen-5-yl)carbamosele-
noyl)thiophene-2-carboxamide (2)
Yield: 1.20 g, 79%. Yellow solid. m.p.: 170 ꢂC. Anal. Calc. for
C21H16N2OSeS (%): C, 59.57; H, 3.81; N, 6.62; O, 3.78; S,
7.57. Found: C, 59.39; H, 3.29; N, 6.42; O, 3.78; S, 7.44.
UV–vis (DMF): kmax, nm 274, 321. FT-IR: V, cmꢁ1 3377,
3298 (N ꢁ H), 3058 (¼C ꢁ H), 1665 (C ¼ O), 1273 (C ¼ Se).
1H NMR (500 MHz, CDCl3): d, ppm 11.28 (s, 1H, NH), 8.77
(s, 1H, NH), 7.65 (d, J ¼ 7.2 Hz, 2H), 7.60 (d, J ¼ 4.7 Hz,
1H), 7.56 (d, J ¼ 2.9 Hz, 2H), 7.44 (d, J ¼ 7.6 Hz, 3H), 7.40
(td, J ¼ 7.5, 1.0 Hz, 3H), 7.34 (t, J ¼ 7.1Hz, 1H), 6.79 (s, 1H),
6.37 (d, J ¼ 2.0 Hz, 1H). 13C NMR (125 MHz, CDCl3): d,
ppm 177.9 (C ¼ Se), 160.5 (C ¼ O), 136.4, 136.1, 133.7,
[4] Jung, H. J.; Seo, Y. R. Current Issues of Selenium in Cancer
Chemoprevention. BioFactors 2010, 36, 153–158. DOI: 10.1002/
ꢀ
[5] Hughes, D. J.; Fedirko, V.; Jenab, M.; Schomburg, L.; Meplan,
C.; Freisling, H.; Bueno-De-Mesquita, H. B.; Hybsier, S.; Becker,
N. P.; Czuban, M.; et al. Selenium Status is Associated with
Colorectal Cancer Risk in the European Prospective
Investigation of Cancer and Nutrition Cohort. Int. J. Cancer
131.0, 130.4, 129.7, 128.8, 128.3, 127.8. LC-MS
¼
407.8 [M–H]–.